Soleno shareholders elect director, ratify auditor, and approve expanded equity incentive plan

SOLENO THERAPEUTICS INC

Andrew Sinclair elected as Class I director with 93.3% of votes cast (26.4M for, 1.9M withheld).
Marcum LLP ratified as independent auditor for FY 2024 (29.2M for, 135K against).
Amended 2014 Equity Incentive Plan approved (19.4M for, 8.9M against); share pool set at 5,825,762 shares plus annual 4% evergreen increase.
Voter turnout of 87.7% (29,312,453 of 33,411,329 shares outstanding).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.